Lightbridge Executive Vice President Dr. Andrey Mushakov Appointed to U.S. Nuclear Industry Council Board of Directors
Lightbridge Corporation
RESTON, Va., May 06, 2025 (GLOBE NEWSWIRE) -- May 6, 2025 – Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced that Dr. Andrey Mushakov, Executive Vice President for Nuclear Operations, has been appointed to the Board of Directors of the U.S. Nuclear Industry Council (USNIC), the leading U.S. business consortium advocate for nuclear energy and promotion of the American supply chain globally.
Dr. Mushakov's appointment to the USNIC Board of Directors will enhance the Company's ability to collaborate with key stakeholders in advancing nuclear technology innovation. As a board member, Dr. Mushakov will contribute to USNIC's efforts in shaping policies that support the development and deployment of advanced nuclear technologies, including next-generation fuels like Lightbridge Fuel™.
Seth Grae, President and CEO of Lightbridge, commented: "We are proud to have Andrey represent Lightbridge on the USNIC Board of Directors. His expertise in nuclear fuel technology and deep understanding of the industry will be valuable assets to the Council as it works to advance nuclear energy in the United States and globally. This appointment reflects the growing recognition of Lightbridge's innovative nuclear fuel technology and our role in shaping the future of clean energy."
Dr. Andrey Mushakov added: "I am honored to join the USNIC Board of Directors and look forward to working with fellow board members to promote the vital role of nuclear energy in addressing energy security challenges. This opportunity aligns with Lightbridge's ongoing efforts to develop and commercialize advanced nuclear fuel technology designed to enhance the safety, economics, and performance of nuclear energy which is essential to power data centers and fuel the growth of AI-driven economy"
About the U.S. Nuclear Industry Council
The United States Nuclear Industry Council (USNIC) is the leading U.S. business consortium advocate for nuclear energy and promotion of the American supply chain globally. USNIC represents approximately 80 companies engaged in nuclear innovation and supply chain development, including technology developers, manufacturers, construction engineers, key utility movers, and service providers. USNIC's educational programs, industry insights, and market intelligence bring together strategic nuclear industry leaders to help the American nuclear industry succeed in the domestic and global markets.
About Lightbridge Corporation
Lightbridge Corporation (NASDAQ: LTBR) is focused on developing advanced nuclear fuel technology essential for delivering abundant, zero-emission, clean energy and providing energy security to the world. The Company is developing Lightbridge Fuel™, a proprietary next-generation nuclear fuel technology for existing light water reactors and pressurized heavy water reactors, significantly enhancing reactor safety, economics, and proliferation resistance. The Company is also developing Lightbridge Fuel for new small modular reactors (SMRs) to bring the same benefits plus load-following with renewables on a zero-carbon electric grid.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
30 minutes ago
- Bloomberg
Klarna Founder's VC Firm Pledges €300 Million Investment in AI
Swedish impact investor Norrsken VC has pledged to invest €300 million ($348 million) in artificial intelligence startups that aim to help solve some of the climate's most pressing needs. The venture capital firm, founded by Klarna co-founder Niklas Adalberth, plans to invest in AI companies alongside its early-stage funds Norrsken Accelerator and Norrsken Launcher, according to a statement on Wednesday.
Yahoo
34 minutes ago
- Yahoo
Lifeward Announces Pricing of $2.6 Million Public Offering
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) ('Lifeward' or the 'Company'), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a public offering of an aggregate of 4,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company's ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant. The ordinary warrants will have an exercise price of $0.65 per ordinary share, will be exercisable immediately upon issuance and will expire on the five-year anniversary of the issuance date. The closing of the offering is expected to occur on or about June 26, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.6 million before deducting the placement agent's fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the ordinary warrants, if fully exercised on a cash basis, will be approximately $2.6 million. No assurance can be given that any of the ordinary warrants will be exercised. The Company intends to use the net proceeds from this offering for its continuing commercial efforts, working capital and general corporate purposes. The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-288172), as amended, which was declared effective by the Securities and Exchange Commission (the "SEC") on June 25, 2025. The offering is being made only by means of a prospectus forming part of the effective registration statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at and a final prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC's website at and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Lifeward Ltd. Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. Lifeward®, ReWalk®, ReStore®, and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates. Forward-Looking Statements In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include statements related to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds from the offering, the exercise of the ordinary warrants prior to their expiration and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward's control. Important factors that could cause the Company's actual results to differ materially from those indicated in the forward-looking statements, including risks and uncertainties related to market conditions, are more fully discussed in the Company's periodic filings with the SEC, including the risk factors described under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 7, 2025 and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company's actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise. Lifeward Media Relations: Kathleen O'DonnellVice President, Marketing & New Business DevelopmentLifeward Ltd.E: media@ Lifeward Investor Contact:Mike LawlessChief Financial OfficerLifeward Ltd.E: ir@
Tom's Guide
34 minutes ago
- Tom's Guide
Google Gemini under fire for major privacy change — what you need to know
A new series of emails regarding changes to Google Gemini has reportedly been sent to some users. However, the information presented has raised some concerns about just how much information the AI will have access to. According to a report from Android Authority, users have taken to social media and discussion boards to question a new email sent to them from Google. This email seemingly details changes around how Gemini will interact with apps on Android devices. Supposedly, from July 7, Gemini will be able to "help you use Phone, Messages, WhatsApp, and Utilities on your phone." While Google sending this kind of email wouldn't be outside of the realms of possibility, the actual wording is very strange. For instance, it states that users can turn off the features in the settings page, but it doesn't have any other information on how to do this. Not only that, it also states that Gemini will have access to the apps mentioned regardless of whether you have Gemini App Activity turned on or off. Currently, when Google Gemini Apps Activity is activated, Google will store all the relevant information — like chats with the app — in your Google account. This means that you can quickly review prompts, responses and feedback. However, you can elect to turn it off, as well as delete your history, while also being sure that Google won't use your data to train and improve Gemini products. As such, the email stating that it doesn't matter if the feature is on or off is pretty concerning. Especially considering the amount of private information on many of those apps and Google's practice of holding information for 72 hours. Even though it could mean that the Gemini app offers a more enhanced experience for users. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. It should be noted that these emails seem to have been sent to a small number of people. We checked many of the devices at Tom's Guide and didn't find any mention of the changes. As such, it is worth withholding judgment for the time being until we have a clear answer. I have reached out to Google looking for confirmation and clarity, and will update this piece as soon as I hear anything.
